HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Lynn Mitchell Selected Research

Ocular Motility Disorders (Convergence Insufficiency)

1/2021Effectiveness of vergence/accommodative therapy for accommodative dysfunction in children with convergence insufficiency.
1/2017Vision Therapy for Binocular Dysfunction Post Brain Injury.
1/2017Objective Assessment of Vergence after Treatment of Concussion-Related CI: A Pilot Study.
10/2016Behavioral and Emotional Problems Associated With Convergence Insufficiency in Children: An Open Trial.
10/2015Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART): Design and Methods.
10/2012Symptoms in children with convergence insufficiency: before and after treatment.
1/2012Improvement in academic behaviors after successful treatment of convergence insufficiency.
11/2011Treatment of accommodative dysfunction in children: results from a randomized clinical trial.
8/2010Vision therapy/orthoptics for symptomatic convergence insufficiency in children: treatment kinetics.
6/2009Effectiveness of placebo therapy for maintaining masking in a clinical trial of vergence/accommodative therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Lynn Mitchell Research Topics

Disease

17Refractive Errors (Refractive Error)
01/2017 - 11/2004
13Ocular Motility Disorders (Convergence Insufficiency)
01/2021 - 01/2005
8Dry Eye Syndromes (Dry Eye Syndrome)
09/2006 - 07/2002
7Myopia
01/2021 - 03/2003
2Strabismus (Squint)
01/2017 - 08/2006
2Hyperopia (Hypermetropia)
07/2005 - 03/2003
2Keratoconus
04/2005 - 08/2002
2Hypoxia (Hypoxemia)
01/2003 - 10/2002
1Brain Injuries (Brain Injury)
01/2017
1Vision Disorders (Hemeralopia)
01/2017
1Ulcer
01/2016
1Keratitis
01/2016
1Eye Infections
08/2015
1Infections
08/2015
1Acanthamoeba Keratitis
08/2015
1AIDS-Related Complex (ARC)
05/2006
1Presbyopia
05/2006
1Birth Weight (Birth Weights)
09/2005
1Pathologic Dilatation (Ectasia)
07/2004

Drug/Important Bio-Agent (IBA)

12Mydriatics (Cycloplegics)IBA
01/2017 - 11/2004
2HydrogelsIBA
10/2009 - 01/2003
2Cyclopentolate (Cyclogyl)FDA LinkGeneric
06/2009 - 09/2005
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
09/2005 - 11/2004
2Phenolsulfonphthalein (Phenol Red)IBA
11/2004 - 04/2004
2Rose BengalIBA
11/2004 - 04/2004
2Fluorescein (Funduscein)FDA LinkGeneric
11/2004 - 04/2004
1SiliconesIBA
10/2009
1lotrafilcon AIBA
10/2009
1paragonIBA
06/2006
1SolutionsIBA
10/2005
1Oxygen (Dioxygen)IBA
10/2002

Therapy/Procedure

14Therapeutics
01/2021 - 01/2005
14Contact Lenses
01/2021 - 07/2002
5Orthoptics (Orthoptic)
11/2011 - 01/2005
5Meridians (Jing Luo)
03/2011 - 03/2003
3Aftercare (After-Treatment)
10/2016 - 03/2005
3Lenses
06/2006 - 08/2002
3Laser In Situ Keratomileusis (LASIK)
05/2005 - 07/2004
2Eyeglasses (Spectacles)
01/2012 - 06/2005
2Hydrophilic Contact Lenses (Hydrophilic Contact Lens)
10/2009 - 05/2006
1Telescopes
01/2017
1Refractive Surgical Procedures
12/2005
1Penetrating Keratoplasty
04/2005
1Slit Lamp
04/2004